近端主动脉弓胸主动脉腔内修复术中弓部血管血运重建技术的比较分析
基于血管质量倡议(VQI)2014至2023年数据,纳入409例接受覆盖全部主动脉弓血管的0区弓部胸主动脉腔内修复术(TEVAR)患者,比较开放、腔内和杂交三种头臂血管血运重建技术的围术期死亡与卒中风险。结果显示腔内血运重建组卒中率显著高于开放组和杂交组,但该差异在2021至2023年间不再显著,杂交技术使用比例上升而腔内技术使用下降。
要点
- 0区弓部TEVAR覆盖全部弓部血管患者中,开放、腔内、杂交血运重建分别占50%、20%、30%。
- 腔内血运重建组围术期卒中风险约为开放组的2倍(OR 2.16,95%CI 1.08-4.30,P=0.03)。
- 2017至2020年间开放与杂交组卒中率显著低于腔内组,但2021至2023年间差异不再显著。
核心结论
- 0区弓部TEVAR期间卒中仍是重要关注问题,完全腔内修复主动脉弓与开放和杂交头臂血管血运重建相比,卒中风险增加两倍以上。
- 腔内血运重建技术进步和杂交策略使用增加提示向更安全、侵入性更小的方法持续演变,使围术期卒中率随时间下降。
研究设计与样本
- 回顾性队列研究,数据来源于血管质量倡议(VQI)2014至2023年,纳入409例接受覆盖全部主动脉弓血管的0区弓部TEVAR患者,排除因主动脉破裂或创伤接受治疗者。
- 头臂血管血运重建技术分为三组:开放血运重建(OR)、腔内血运重建(ER)和杂交血运重建(HR)。
- 采用多因素logistic回归分析评估头臂血管血运重建技术与围术期死亡和卒中主要结局的关联。
主要发现
- 409例患者中,50%(207/409)接受OR,20%(80/409)接受ER,30%(122/409)接受HR。
- 院内死亡率和卒中率分别为9%和12%,30天、1年和2年生存率分别为88%、79%和74%。
- ER组卒中率显著高于OR组和HR组(OR 11%,ER 21%,HR 8%;P=0.02)。
- ER与OR相比围术期卒中风险约高两倍(比值比2.16;95%置信区间1.08-4.30;P=0.03),OR与HR之间围术期卒中无差异(P=0.40)。
- 2017至2020年间OR和HR围术期卒中率显著低于ER(OR 10% vs ER 30% vs HR 10%,P=0.02),但最近研究区间(2021至2023年)该差异不再显著(OR 9% vs ER 12% vs HR 8%;P=0.76)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular stent grafting extending into the ascending aorta (zone 0) is increasingly used in the treatment of aortic arch disease. This study aims to evaluate the risk of stroke in patients undergoing zone 0 arch thoracic endovascular aortic repair (TEVAR) based on the technique used for head vessel revascularization. METHODS: Patients undergoing zone 0 arch TEVAR covering all the aortic arch vessels were identified in the Vascular Quality Initiative between 2014 and 2023. Patients treated for aortic rupture or trauma were excluded. Head vessel revascularization techniques were classified into three groups: open revascularization (OR), endovascular revascularization (ER), and hybrid revascularization (HR). Multivariate logistic regression analysis was used to evaluate the association of head vessel revascularization technique with the primary outcomes of perioperative mortality and stroke. RESULTS: A total of 409 patients underwent zone 0 arch TEVAR covering all the aortic arch vessels, of which 50% (207/409) underwent OR, 20% (80/409) underwent ER, and 30% (122/409) underwent HR of the head vessels. The in-hospital mortality and stroke rates were 9% and 12%, respectively. Survival at 30 days, 1 year, and 2 years were 88%, 79%, and 74%, respectively. Patients undergoing ER of the head vessels had significantly higher stroke compared with those undergoing OR and HR (OR 11%, ER 21%, HR 8%; P = .02). ER was associated with a two-fold higher risk of perioperative stroke compared with OR (odds ratio, 2.16; 95% confidence interval, 1.08-4.30; P = .03), whereas no difference in perioperative stroke was observed between OR and HR (P = .40). Although OR and HR of the head vessels had a significantly lower rate of perioperative stroke compared with ER in 2017-2020 (OR 10% vs ER 30% vs HR 10%, P = .02), this difference diminished over time with no significant difference observed in the most recent interval (2021-2023) studied (OR 9% vs ER 12% vs HR 8%; P = .76). Trends revealed an increase in the use of HR (from 4% in 2014 to 57% in 2023) alongside a significant decrease in ER (from 39% in 2020 to 14% in 2023). CONCLUSIONS: Stroke remains a significant concern during zone 0 arch TEVAR. Total endovascular repair of the aortic arch is associated with a greater than two-fold higher risk of stroke compared with OR and HR of the head vessels. However, advances in ER techniques and increased use of hybrid strategies highlight an ongoing evolution toward safer and less invasive approaches resulting in a decrease in perioperative stroke rates over time.
引用
- Chamseddine H, Halabi M, Shepard A, et al. Comparative analysis of arch vessel revascularization techniques in proximal arch thoracic endovascular aortic repair. J Vasc Surg. 2025. PMID: 40180163. doi:10.1016/j.jvs.2025.03.203
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。